The changing spectrum of cutaneous leishmaniasis and HIV coinfection in Bolivian Amazonia: a case report.

Trans R Soc Trop Med HygSep 2, 2026

Alfonso Gotor-Rivera, Mayber Lenin Aparicio-Loayza, Rodrigo Federico Matilla Naumionek et al.

✦ AI-curated · Sources linked

Case in brief

A 34-year-old man with advanced HIV infection presented with localized cutaneous leishmaniasis that progressed despite treatment with pentavalent antimonials. He developed numerous widespread ulcerated papules and nodules, along with systemic symptoms and significant weight loss. Diagnosis was confirmed through skin smears and histopathology showing intracellular amastigotes. Treatment with liposomal amphotericin B and oral miltefosine resulted in only temporary clinical improvement.

Diagnostic / clinical pearl

Clinicians should be aware of the potential for cutaneous leishmaniasis to present atypically and progress rapidly in immunocompromised patients, complicating diagnosis and treatment.

Why it matters

This case illustrates the evolving clinical spectrum of cutaneous leishmaniasis in the context of HIV, emphasizing the need for heightened awareness and tailored management strategies in such patients.

Source

Published in Trans R Soc Trop Med Hyg. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.